{"id":"https://openalex.org/W3149728916","doi":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","title":"Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram","display_name":"Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W3149728916","doi":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","mag":"3149728916"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v130.suppl_1.701.701","doi":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053040794","display_name":"Surbhi Saini","orcid":"https://orcid.org/0000-0003-2911-6675","observed_orcids":["https://orcid.org/0000-0003-2911-6675"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surbhi Saini","raw_affiliation_strings":["Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH","institution_ids":["https://openalex.org/I1314135232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032813653","display_name":"Katherine L Harsh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine L Harsh","raw_affiliation_strings":["The Ohio State University College of Medicine, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University College of Medicine, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027676114","display_name":"Joseph R. Stanek","orcid":"https://orcid.org/0000-0003-1630-2102","observed_orcids":["https://orcid.org/0000-0003-1630-2102"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph R Stanek","raw_affiliation_strings":["Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH","institution_ids":["https://openalex.org/I1314135232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050829820","display_name":"Sarah H. O\u2019Brien","orcid":"https://orcid.org/0000-0001-8855-9746","observed_orcids":["https://orcid.org/0000-0001-8855-9746","https://orcid.org/0000-0001-9939-6292"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah O'Brien","raw_affiliation_strings":["Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH","The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051210012","display_name":"Amy L. Dunn","orcid":"https://orcid.org/0000-0002-9645-6365","observed_orcids":["https://orcid.org/0000-0002-9645-6365"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy L. Dunn","raw_affiliation_strings":["Division of Hematology/Oncology/BMT, Nationwide Childrens Hospital, Columbus, OH","The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology/BMT, Nationwide Childrens Hospital, Columbus, OH","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044775562","display_name":"Riten Kumar","orcid":"https://orcid.org/0000-0001-8004-4190","observed_orcids":["https://orcid.org/0000-0001-8004-4190"]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riten Kumar","raw_affiliation_strings":["Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH","The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH","institution_ids":["https://openalex.org/I1314135232"]},{"raw_affiliation_string":"The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"130","issue":"Suppl_1","first_page":"701","last_page":"701"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0835999995470047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/unfractionated-heparin","display_name":"unfractionated heparin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pediatric-anticoagulation","display_name":"pediatric anticoagulation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/nomogram","display_name":"nomogram","score":0.6039999723434448},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9599999785423279},{"id":"https://openalex.org/keywords/heparin-dosing","display_name":"heparin dosing","score":0.753000020980835},{"id":"https://openalex.org/keywords/infants","display_name":"infants","score":0.3779999911785126},{"id":"https://openalex.org/keywords/critically-ill-children","display_name":"critically ill children","score":0.6169999837875366},{"id":"https://openalex.org/keywords/anticoagulation-monitoring","display_name":"anticoagulation monitoring","score":0.6290000081062317},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.47999998927116394},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.4180000126361847},{"id":"https://openalex.org/keywords/heparin-induced-thrombocytopenia","display_name":"heparin-induced thrombocytopenia","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8668746948242188},{"id":"https://openalex.org/C34626388","wikidata":"https://www.wikidata.org/wiki/Q721129","display_name":"Nomogram","level":2,"score":0.8654353618621826},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7068181037902832},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.6192977428436279},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5535356998443604},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5438634753227234},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.445813924074173},{"id":"https://openalex.org/C2776472838","wikidata":"https://www.wikidata.org/wiki/Q1598365","display_name":"Heparin-induced thrombocytopenia","level":3,"score":0.41206637024879456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40460625290870667},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35535335540771484},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.19029384851455688}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v130.suppl_1.701.701","doi":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v130.suppl_1.701.701","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2933598993","https://openalex.org/W1522064867","https://openalex.org/W1964477223","https://openalex.org/W2169866483","https://openalex.org/W2288932954","https://openalex.org/W2169291800","https://openalex.org/W4311651281","https://openalex.org/W1996577728","https://openalex.org/W4379742088","https://openalex.org/W2529985853"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Given":[2],"its":[3],"short":[4],"half-life":[5],"and":[6,66,82,180,184,198,243,281,296,313,332,379,399,403,419,426,440,461,470,486,595],"immediate,":[7],"complete":[8],"reversibility":[9],"with":[10,176,346,417,424,464,494,508],"protamine":[11],"sulfate,":[12],"unfractionated":[13],"heparin":[14],"(UFH)":[15],"remains":[16],"the":[17,78,115,140,166,209,377,393],"anticoagulant":[18,521,569],"of":[19,27,45,52,117,156,257,288,369,415,445,468,503,518,524,546,566,572,584,648,656],"choice":[20],"for":[21,134,147,172,212,392,431,532],"critically-ill":[22],"children.":[23,480],"The":[24],"American":[25],"College":[26],"Chest":[28],"Physicians":[29],"recommends":[30],"that":[31],"a":[32,126,217,321],"therapeutic":[33,154,272,305,341,364,484],"activated":[34],"partial":[35,356],"thromboplastin":[36],"time":[37,90,302],"(APTT)":[38],"range":[39],"in":[40,123,252,285,317,457,479,489,522,535,570],"children":[41,124,293],"on":[42,97,454,542,580,652],"treatment":[43,523],"doses":[44],"UFH":[46,120,157,171,223,258,267,475],"should":[47],"reflect":[48],"an":[49,69,73,465,543,581,653],"anti-FXa":[50,74,83,98,118,244,273,342,365,380],"level":[51],"0.35-0.7":[53],"IU/mL.":[54],"A":[55],"previous":[56,495,499],"study":[57,136,167,517,565],"from":[58,139],"our":[59,106,232,490],"institution":[60],"showed":[61],"moderate":[62],"correlation":[63,375],"between":[64,376],"APTT":[65,81,242,378,449,504],"anti-FXa,":[67,434],"prompting":[68],"institution-wide":[70],"change":[71],"to":[72,270,291,303,325,362,422,482,498],"based":[75,119],"nomogram.":[76,111],"Per":[77],"new":[79],"nomogram,":[80],"levels":[84,99],"were":[85,95,190,193,200,206,409,442],"simultaneously":[86],"collected":[87],"at":[88,160,225],"pre-specified":[89,233],"points,":[91],"though":[92],"dose":[93,268],"titrations":[94],"made":[96,201],"alone.":[100],"In":[101,344],"this":[102,110,135],"study,":[103],"we":[104],"present":[105],"20-month":[107,127,218],"experience":[108],"using":[109,195,202,208],"Objectives:":[112],"To":[113],"assess":[114],"utility":[116],"dosing":[121,155],"guidelines":[122],"over":[125,165],"period":[128],"(September":[129],"2015-May":[130],"2017).":[131],"Methods:":[132],"Permission":[133],"was":[137,145,260,275,282,307,314,366,390,452,505],"obtained":[138],"Institutional":[141],"Review":[142],"Board.":[143],"Data":[144,192],"abstracted":[146],"all":[148],"pediatric":[149,525,573],"patients":[150,175,185,221,230,238,318,338,345,416,460],"(age<21":[151],"yrs.)":[152],"receiving":[153,170,186],"(\u226518":[158],"u/kg/hr)":[159],"Nationwide":[161],"Children's":[162],"Hospital":[163],"(NCH)":[164],"period.":[168],"Patients":[169],"<24":[173],"hrs,":[174],"mechanical":[177],"circuits":[178],"(ECMO":[179],"ventricular":[181],"assist":[182],"devices),":[183],"concomitant":[187],"anti-platelet":[188],"therapy":[189,224,259],"excluded.":[191],"analyzed":[194],"descriptive":[196],"statistics":[197],"comparisons":[199],"non-parametric":[203],"methods.":[204],"Correlations":[205],"assessed":[207],"Bland-Altman":[210],"method":[211],"repeated":[213],"measures.":[214],"Results:":[215],"Over":[216],"period,":[219],"176":[220],"received":[222,320],"NCH.":[226],"Of":[227],"these,":[228],"95":[229,237],"met":[231],"inclusion":[234],"criteria.":[235],"These":[236],"had":[239,350],"1102":[240],"simultaneous":[241],"measurements":[245],"performed.":[246],"Baseline":[247],"demographic":[248],"information":[249],"is":[250,477,492],"described":[251],"Table":[253],"1.":[254],"Mean":[255],"duration":[256],"5.2":[261],"days":[262],"(range:":[263,278,310],"1-45":[264],"days).":[265],"Median":[266,301],"required":[269],"reach":[271],"goal":[274],"22":[276],"units/kg/hr":[277],"18-55":[279],"units/kg/hr),":[280],"significantly":[283,315],"higher":[284],"infants":[286],"(<1yr":[287],"age)":[289],"compared":[290,324],"older":[292],"(33.9":[294],"u/kg":[295,298],"20":[297],"respectively;":[299,335],"p<0.0001).":[300],"achieve":[304,363,483],"anti-Xa":[306],"10":[308,404],"hours":[309],"2-96":[311],"hours),":[312],"shorter":[316],"who":[319,327],"bolus":[322],"(n=44)":[323],"those":[326,423],"did":[328],"not":[329,367,443,462,506],"(5":[330],"hrs":[331,334],"12":[333],"p=0.03).":[336],"Five":[337],"never":[339],"achieved":[340],"levels.":[343],"thrombo-embolism":[347],"(n=75),":[348],"65":[349],"end-of-therapy":[351],"imaging":[352],"(complete":[353],"response:":[354,359],"36;":[355],"or":[357,548,586,658],"no":[358],"29).":[360],"Time":[361,481],"predictive":[368,444],"radiological":[370],"response":[371],"(p=0.27).":[372],"Moderate":[373],"linear":[374],"(r":[381],"=":[382,386],"0.74;":[383],"95%":[384],"CI":[385],"0.71-0.77)":[387],"(Figure":[388],"1)":[389],"noted":[391,453],"entire":[394],"cohort.":[395],"Eleven":[396],"(10.6%)":[397],"major":[398,418,469],"non-major":[400,420,471],"bleeding":[401,407,421,428,487,510],"events":[402,408],"(10.5%)":[405],"minor":[406,427],"noted.":[410],"When":[411],"comparing":[412],"coagulation":[413],"parameters":[414],"no-bleeding":[425],"age,":[429],"indication":[430],"anticoagulation,":[432],"peak":[433,435],"APTT,":[436],"lowest":[437],"platelet":[438],"count":[439],"fibrinogen":[441],"bleeding.":[446],"Critically":[447],"high":[448],"(>250":[450],"sec)":[451],"43":[455],"occasions":[456],"21":[458],"unique":[459],"associated":[463,507],"increased":[466,509],"risk":[467,488],"bleeds":[472],"(p=0.07).":[473],"Conclusions:":[474],"monitoring":[476],"challenging":[478],"anticoagulation":[485],"cohort":[491],"consistent":[493],"publications.":[496],"Contrary":[497],"publications,":[500],"extreme":[501],"elevation":[502],"risk.":[511],"Disclosures":[512],"O'Brien:":[513],"Pfizer:":[514],"Consultancy,":[515,604,625,641],"Other:":[516,530,551,564,589,599,605,610,615,620,626,633,642],"direct":[519,567],"oral":[520,568],"VTE;":[526,537],"Glaxo":[527],"Smith":[528],"Kline:":[529],"DSMB":[531],"Arixtra":[533],"Study":[534],"Pediatric":[536],"CSL":[538,639,664],"Behring:":[539,640,665],"Honoraria,":[540,578],"Membership":[541,579,651],"entity's":[544,582,654],"Board":[545,583,655],"Directors":[547,585,657],"advisory":[549,552,587,590,659],"committees,":[550,588],"board":[553,591],"-":[554,592],"von":[555],"Willebrand":[556],"Disease":[557],"diagnosis":[558,594],"&":[559],"management;":[560],"Bristol":[561],"Myers":[562],"Squibb:":[563],"prevention":[571],"VTE,":[574],"Research":[575,630,637],"Funding;":[576,631,638],"Shire:":[577,624],"VWD":[593],"management.":[596],"Dunn:":[597],"Alnylam:":[598],"Unrestricted":[600,606,611,616,621,627,634,643],"educational":[601,607,612,617,622,628,635,644],"grant;":[602,608,613,618,623,645],"Bayer:":[603,662],"Kedrion:":[609],"NovoNordisk:":[614],"Octapharma:":[619],"grant,":[629,636],"Biogen:":[632],"World":[646],"Federation":[647],"Hemophilia":[649],"USA:":[650],"committees.":[660],"Kumar:":[661],"Consultancy;":[663],"Consultancy.":[666]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2021-04-13T00:00:00"}